Iron-chelated semiconducting oligomer nanoparticles for NIR-II fluorescence imaging-guided enhanced chemodynamic/photothermal combination therapy

Abstract

Chemodynamic therapy (CDT) has attracted increasing attention owing to its high tumor specificity and low number of side effects. However, the low absolute concentration of reactive oxygen species (ROS) within tumor cells restricts the CDT efficacy. Herein, we use dihydroartemisinin (DHA) to enhance the CDT efficacy and combine photothermal therapy (PTT) to further improve the anticancer effect. To achieve such a goal, an iron-containing semiconducting oligomer nanoparticle (DHA@FePSOD) is prepared by loading DHA into a Fe³⁺-chelated NIR-II fluorescent semiconducting oligomer (FePSOD). The Fe³⁺ ion within DHA@FePSOD can be reduced to the Fe²⁺ ion by glutathione (GSH) and subsequently catalyze the decomposition of hydrogen peroxide (H₂O₂) into the highly toxic hydroxyl radical (˙OH) for CDT. The loaded DHA may be further reduced by Fe²⁺ and generate a DHA radical to enhance the CDT efficacy. In addition, DHA@FePSOD shows a good photothermal effect and intense NIR-II fluorescence signal under 808 nm laser irradiation. Both in vitro and in vivo studies prove the better anticancer effect of DHA@FePSOD than FePSOD, which is attributed to the loaded DHA. Furthermore, DHA@FePSOD can effectively accumulate into a tumor and delineate the tumor via NIR-II fluorescence imaging. This study thus provides an efficient approach for developing a NIR-II fluorescence imaging-guided enhanced chemodynamic/photothermal combination therapeutic nanoplatform.